1. Home
  2. CING vs SYNX Comparison

CING vs SYNX Comparison

Compare CING & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • SYNX
  • Stock Information
  • Founded
  • CING 2012
  • SYNX 2005
  • Country
  • CING United States
  • SYNX Israel
  • Employees
  • CING N/A
  • SYNX N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • SYNX
  • Sector
  • CING Health Care
  • SYNX
  • Exchange
  • CING Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • CING 16.2M
  • SYNX 13.7M
  • IPO Year
  • CING 2021
  • SYNX 2024
  • Fundamental
  • Price
  • CING $4.25
  • SYNX $1.72
  • Analyst Decision
  • CING Strong Buy
  • SYNX
  • Analyst Count
  • CING 4
  • SYNX 0
  • Target Price
  • CING $30.67
  • SYNX N/A
  • AVG Volume (30 Days)
  • CING 104.9K
  • SYNX 133.9K
  • Earning Date
  • CING 08-12-2025
  • SYNX 05-14-2025
  • Dividend Yield
  • CING N/A
  • SYNX N/A
  • EPS Growth
  • CING N/A
  • SYNX N/A
  • EPS
  • CING N/A
  • SYNX N/A
  • Revenue
  • CING N/A
  • SYNX $9,094,000.00
  • Revenue This Year
  • CING N/A
  • SYNX $32.35
  • Revenue Next Year
  • CING N/A
  • SYNX N/A
  • P/E Ratio
  • CING N/A
  • SYNX N/A
  • Revenue Growth
  • CING N/A
  • SYNX 19.14
  • 52 Week Low
  • CING $1.80
  • SYNX $1.56
  • 52 Week High
  • CING $20.83
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • CING 59.00
  • SYNX 46.39
  • Support Level
  • CING $3.97
  • SYNX $1.56
  • Resistance Level
  • CING $4.26
  • SYNX $1.91
  • Average True Range (ATR)
  • CING 0.27
  • SYNX 0.18
  • MACD
  • CING 0.00
  • SYNX -0.01
  • Stochastic Oscillator
  • CING 74.56
  • SYNX 22.22

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: